Billy Evans, associate of Theranos founder Elizabeth Holmes, is engaged on a brand new startup that seeks to ship “human well being optimization” by blood testing, according to The New York Times.
The Instances reportedly spoke to 2 traders pitched on the startup, known as Haemanthus, and likewise seen a few of Haemanthus’ advertising and marketing supplies.
In these supplies, the corporate says it has developed a machine that makes use of lasers to research blood, saliva, and urine samples to detect most cancers and infections. It reportedly plans to begin with pet well being earlier than increasing to people, and it seeks to boost greater than $50 million.
The pitch echoes that for Theranos, which promised to conduct a wide range of medical exams on tiny quantities of blood drawn from pricked fingers. In 2022, Holmes (with whom Evans has two youngsters) was sentenced to 11 years in prison for defrauding traders, although she said in a recent interview that she stays “fully dedicated to my dream of constructing reasonably priced healthcare options out there to everybody.”
Early Fb investor Jim Breyer informed The Instances that his workforce was requested to speculate however declined “for most of the similar causes we handed twice on Theranos.”
Trending Merchandise
